CVS Stock Down -5.4% after 7-Day Loss Streak
CVS Health (CVS) stock hit day 7 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -5.4% return. The company has lost about $4.4 Bil in value over the last 7 days, with its current market capitalization at about $81 Bil. The stock remains 44.3% above its value at the end of 2024. This compares with year-to-date returns of 7.1% for the S&P 500.
Comparing CVS Stock Returns With The S&P 500
The following table summarizes the return for CVS stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | CVS | S&P 500 |
|---|---|---|
| 1D | -0.8% | 0.5% |
| 7D (Current Streak) | -5.4% | 1.2% |
| 1M (21D) | -6.2% | 5.4% |
| 3M (63D) | -7.6% | 16.5% |
| YTD 2025 | 44.3% | 7.1% |
| 2024 | -40.8% | 23.3% |
| 2023 | -12.5% | 24.2% |
| 2022 | -7.6% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 20 S&P constituents with 3 days or more of consecutive gains and 37 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 7 | 20 |
| 4D | 10 | 5 |
| 5D | 0 | 7 |
| 6D | 0 | 1 |
| 7D or more | 3 | 4 |
| Total >=3 D | 20 | 37 |
Key Financials for CVS Health (CVS)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $357.8 Bil | $372.8 Bil |
| Operating Income | $14.6 Bil | $9.8 Bil |
| Net Income | $8.3 Bil | $4.6 Bil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
|---|---|---|
| Revenues | $97.7 Bil | $94.6 Bil |
| Operating Income | $2.5 Bil | $3.4 Bil |
| Net Income | $1.6 Bil | $1.8 Bil |
The losing streak CVS stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.